Table 2. Characteristics of study participants.
|
No |
Author, year |
Sample size (n) |
Age, year* |
Male, % (n) |
Pain scale |
|||
|
SAPB |
Control |
SAPB |
Control |
SAPB |
Control |
|||
|
1 |
El Malla et al.20, 2022 |
25 |
25 |
34.4±12.35 |
35.8±11.56 |
68 (17) |
80 (20) |
NRS |
|
2 |
Zengin et al.14, 2025 |
30 |
30 |
53 [18] |
44 [27.75] |
70 (21) |
66.67 (20) |
VAS |
|
3 |
Tekşen et al.11, 2021 |
30 |
30 |
50.7±18.8 |
42.4±15.8 |
36.67 (11) |
23.33 (7) |
NRS |
|
4 |
Abu-Elwafa et al.21, 2021 |
20 |
20 |
NR |
NR |
NR |
NR |
VAS |
|
5 |
Serra et al.22, 2024 |
75 |
81 |
64 [55–74] |
61 [51–74] |
70.7 (53) |
60.5 (49) |
NRS |
|
6 |
Sadauskas et al.23, 2024 |
15 |
23 |
58±21 |
64±19 |
66 (10) |
43 (10) |
NRS |
|
7 |
Partyka et al.12, 2024 |
103 |
104 |
71 [54–85] |
71 [58–82] |
65 (67) |
60 (62) |
NRS |
*Data are presented as mean ± SD or median (IQR)
**Partyka et al.12baseline characteristics are reported for the analyzed population (103 SAPB, 104 control); 210 patients were initially randomized
n: number of samples, SAPB: serratus anterior plane block, NRS: numeric rating scale, VAS: visual analog scale, SD: standard deviation, IQR: interquartile range